Cel-Sci (CVM) Stock: Buy, Sell, or Hold?
CVM - Cel-Sci Corporation
$1.48
-0.11 (-6.92%)
âŧ
5d:
-4.52%
30d:
-12.95%
90d:
+29.82%
WAIT
LOW Confidence
Analysis Updated: Oct 26, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When CVM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CVM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CVM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CVM is currently trading at $1.48, which is considered fair relative to its 30-day fair value range of $1.55 to $2.11.
Technical Outlook: Technically, CVM is in a strong uptrend. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.9% recently.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.50 (+686.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CVM is in a strong uptrend. The price is currently testing key support at $1.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.9% recently.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.50 (+686.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.55 -
$2.11
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.9%)
- BULLISH: Trading 686.2% below Wall St target ($12.50)
- WARNING: Composite score 49/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.55 -
$2.11
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.50
Resistance Level
$1.93
Current Trend
Strong Uptrend
Technical data as of
Oct 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.25
Wall Street Target
$12.50
(+686.2%)
Revenue Growth (YoY)
-62.7%
Share & Embed Analysis
Last updated: October 27, 2026 10:12 AM ET
Data refreshes hourly during market hours. Next update: 11:12 AM
Data refreshes hourly during market hours. Next update: 11:12 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$259 | 60 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
